Oligonucleotide Manufacturing at Scale: Why Integration, Automation, and System Design Matter
The commercial trajectory of oligonucleotide therapeutics is changing the manufacturing conversation. As more programs advance through clinical development and move toward commercialization, the central question is no longer whether oligonucleotides can be produced at scale. The more pressing issue is how to scale production without compromising product quality, process control, operator safety, or manufacturing efficiency. … Continued